Axtria Blogs

Axtria Blogs

US Supply Chain Challenges In the COVID-19 Pandemic

How the Coronavirus is Causing Havoc in the US Pharma Supply Chain

"When you control the supply of medicines, you control the world."

Rosemary Gibson
Senior Advisor to the Hastings Center, a US-based Bioethics Research Institute and author of
the book, China Rx: Exposing the Risks of America's Dependence on China for Medicine.

Read More
Coronavirus - COVID-19 - AI and Big Data for containment, diagnostic and treatment

COVID-19: AI and Big Data for Treatment, Containment, and Flattening the Curve

As of March 31, there are 857,487 confirmed coronavirus cases and 42,107 deaths globally. On March 27, the U.S. became the official epicenter of the disease, with confirmed tallies surpassing Italy, Spain, and China. Currently, countries’ ongoing lockdowns follow Wuhan, China’s strict measures during the early outbreak, which have only now begun to ease amidst a slowing spread, according to reports.

Read More
Role of AI in Patient Adherence

The Role AI Is Playing In Healthcare Patient Adherence

As per a systemic review1 published in Annals of Internal Medicine, assessing the impact of interventions to improve adherence, it was found that about half the medications prescribed for chronic diseases are not consumed as directed by the physician, and around 20-30% of prescriptions are never fulfilled. This non-adherence results in over 125,000 deaths every year as well as increased emergency department visits and hospitalizations, which costs the American healthcare system to the tune of $100 to $300 billion1.

Read More
Targeting and Call Planning

Improving Targeting and Call Planning for the Changing Pharma Landscape

As the healthcare industry moves toward a value-based paradigm, the healthcare environment is becoming increasingly complex with emerging market influencers. Rising healthcare costs and reforms are tilting the balance of power toward payers and provider networks.

Read More
How Healthcare AI Chatbots Are Transforming the Patient Journey

How Healthcare AI Chatbots Are Transforming the Patient Journey

“Hi Caroline, this is Jeff! You reported feeling heavily symptomatic yesterday. I wanted to see if you are doing better. On a scale from 1-10, how would you rate your pain today?”

Read More

#STEMinism: Girls Lose Interest Through Nurture, Not Nature

In today's technology age, many of the world's fastest-growing and lucrative careers stem from STEM – science, technology, engineering, and math. Unfortunately, STEM industries are still amongst some of the most male-dominated workforces.

Read More

Enabling AI in companies, The Jack Welch way!

Today more than any other day, having started my career in a GE company (the erstwhile GE Capital International Services), I have this involuntary urge to pay my tribute to “Neutron Jack” in my small and perhaps largely insignificant way. But yet, I must, as the words come out, “Straight from the Gut” for the big man, who has left an indelible mark on every individual that he has remotely touched through his rich legacy, leadership, and philosophy.

Read More
Three Rare Disease Diagnoses Opportunities For AI and Machine Learning

Three Rare Disease Diagnoses Opportunities For AI and Machine Learning

The world of health and medicine has broken countless barriers over the last few scores. Life sciences companies have continued to invest significantly in their research of globally corroding diseases, drug molecules discovery and development, and closely monitored clinical trials, to create industry-approved blockbuster medicines. These drugs, gaining precision with time, are curing more diseases and giving patients a chance at better lives. The pharma journey, however, gets complicated with more in-depth clinical and genetic research, as companies continue to find themselves facing more significant ‘unknowns’ than ever before.

Read More
Life Sciences Tech Trends 2020

2020 Emerging Technology Trends in the Life Sciences Industry

The life sciences industry has always been propelled by research and innovation, more now than ever, with breakthrough drug development, massive investments to expedite drug launches, and opportunities for medical advancements. To put this into perspective, let’s consider the clinical development trends for the last ten years. There were more than 16,0001 assets in clinical development in 2019, and almost 1,7002 investigational new drug applications (INDs) were filed, up from 9,700 drugs in clinical development, and 1,300 INDs filed in 20103. Along with substantial investments in drug discovery and research and development, life sciences companies are also transforming in the areas of data management, business intelligence, and analytical capabilities by adopting digital transformation, artificial intelligence (AI), machine learning (ML), NLP (Natural Processing Language), and most pertinently, automation.

Read More

What Managed Care Analytics Means to Pharma Brand Success – Part 2

In Part 1 of this two-part series, we learned about what managed care analytics means for pharma brand success and the factors that pharma companies need to keep in mind while planning their managed care strategy. In this part, we will explore how pharma account managers can leverage managed care analytics, in their constant endeavor of optimized contract performance, better formulary positions, and improved patient access and health outcomes.

Read More

Let Us Show You What Axtria’s 

Solutions Can Do For You